Sera Prognostics Investor Relations Material

Sera Prognostics Inc. is a biotechnology company focused on developing diagnostic tests that predict pregnancy-related complications. The company uses proteomic technologies to identify biomarkers that assess the risk of conditions such as preterm birth and other adverse pregnancy outcomes. Sera Prognostics aims to provide healthcare providers with actionable information to improve maternal and neonatal health through early detection and intervention. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.